https://www.fiercebiotech.com/biotech/perceptive-debuts-lianbio-cancer-and-heart-disease-programs-from-bridgebio-myokardia
Perceptive debuts LianBio with cancer and heart disease programs from BridgeBio, MyoKardia | Fierce...
Aug 11, 2020 - After working in stealth since October, Perceptive Advisors is unveiling its latest biotech: LianBio, which serves the dual mission of bringing much-needed new...
https://markets.businessinsider.com/news/stocks/myokardia-stock-price-bristol-myers-acquire-billion-cash-drug-pharma-2020-10-1029648148
MyoKardia Soars 59% After Bristol-Myers to Acquire It for $13 Billion - Markets Insider
MyoKardia's mavacamten candidate is expected to be submitted to the FDA for approval in the first quarter of 2021.
https://www.colorado.edu/lab/leinwand/2020/11/17/bristol-myers-squibb-acquires-myokardia-inc-biomedical-company-co-founded-cu-professor
Bristol Myers Squibb acquires MyoKardia Inc., a biomedical company co-founded by CU professor |...
bristol myers squibb